Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction

Background. Persistent human immunodeficiency virus (HIV) within the CD4(+) T-cell reservoir is an obstacle to eradication. We hypothesized that adding raltegravir and maraviroc to standard combination antiretroviral therapy (cART) during early HIV infection could substantially reduce viral reservoi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Ostrowski, Mario, Benko, Erika, Yue, Feng Yun, Kim, Connie J., Huibner, Sanja, Lee, Terry, Singer, Joel, Pankovich, Jim, Laeyendecker, Oliver, Kaul, Rupert, Kandel, Gabor, Kovacs, Colin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621663/
https://ncbi.nlm.nih.gov/pubmed/26512359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofv138
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars